A biomimetic Au@BSA-DTA nanocomposites-based contrast agent for computed tomography imaging

Area of Science:

• Biomaterials Science
• Nanotechnology
• Medical Imaging

Background:

• Early cancer detection is crucial for improving patient survival rates.
• Gold nanoparticles have shown significant progress in biological detection applications.
• Development of advanced contrast agents is needed for enhanced medical imaging.

Purpose of the Study:

• To synthesize and characterize a novel gold nanoparticle-based contrast agent for X-ray computed tomography (CT) imaging.
• To evaluate the biocompatibility and hemocompatibility of the developed agent.
• To assess the potential of the agent for early cancer diagnosis.

Main Methods:

• Facile one-pot synthesis of gold nanoparticles (Au@BSA) using bovine serum albumin (BSA) as a biotemplate.
• Conjugation of diatrizoic acid (DTA) to create the Au@BSA-DTA contrast agent.
• Systematic characterization using various techniques, including stability, cytotoxicity, and hemolytic assays.
• Evaluation of CT imaging performance compared to traditional agents.

Main Results:

• The synthesized Au@BSA-DTA nanoparticles demonstrated good colloidal stability across tested pH and temperature ranges.
• Au@BSA-DTA exhibited excellent biocompatibility and hemocompatibility up to 80μg/mL gold concentration.
• The agent displayed a significantly stronger CT imaging effect due to the presence of gold and iodine.

Conclusions:

• The developed biomimetic Au@BSA-DTA material is a promising X-ray CT contrast agent.
• Its superior imaging capabilities and biocompatibility suggest potential for clinical application in early cancer diagnosis.
• This work highlights the utility of nanoparticle-based agents in advancing medical imaging technologies.